PMID: 11901913Mar 21, 2002Paper

Management of small cell lung cancer

Clinics in Chest Medicine
Bruce E Johnson

Abstract

Small cell lung carcinoma typically presents as a central endobronchial lesion in chronic cigarette smokers with hilar enlargement and disseminated disease. The diagnostic pathology should be reviewed by a pathologist accomplished in reading pulmonary pathology, and, if any doubt exists in the diagnosis, additional special stains or diagnostic material should be obtained. Patients with extensive stage disease should be managed by combination chemotherapy, whereas patients with limited stage disease should be treated with etoposide/cisplatin plus concurrent chest irradiation. The chemotherapy should be administered for 4 to 6 months and then should be discontinued. Prophylactic cranial irradiation should be given to patients who achieve a complete remission. Patients should be retreated with chemotherapy if they develop a relapse of their small cell lung cancer. The patients who are followed in complete remission should be observed carefully for second cancers, and appropriate therapy should be administered if the cancer reappears.

References

Mar 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S C GrantE A Kitsis
Feb 5, 1992·Journal of the National Cancer Institute·T D Moore, E L Korn
Jan 1, 1992·Journal of Cancer Research and Clinical Oncology·W JedrychowskiK Gomola
Dec 3, 1992·The New England Journal of Medicine·J P PignonB Lebeau
Aug 1, 1991·International Journal of Radiation Oncology, Biology, Physics·O M SalazarR G Slawson
Sep 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E BorkH H Hansen
Sep 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·U SagmanJ L Yeoh
Feb 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D W MilesS G Spiro
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R P AbrattD G Salton
Feb 21, 1990·Journal of the National Cancer Institute·D P BlissB E Johnson
Feb 1, 1990·Seminars in Oncology·D N CarneyP E Postmus
Oct 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D H JohnsonJ D Hainsworth
Nov 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C W TaylorR B Livingston
Sep 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M L SlevinP F Wrigley
Jun 1, 1988·International Journal of Radiation Oncology, Biology, Physics·E LaukkanenN Murray
Jul 1, 1988·International Journal of Radiation Oncology, Biology, Physics·A T TurrisiB A Mason
Aug 1, 1988·The American Journal of Medicine·B E JohnsonD C Ihde
Jun 1, 1986·Thorax·H R SørensenP Alstrup
Sep 15, 1971·Annals of the New York Academy of Sciences·E H Lambert, D Elmqvist
Sep 26, 1995·Proceedings of the National Academy of Sciences of the United States of America·A S PolansG Adamus
Aug 30, 1995·International Journal of Radiation Oncology, Biology, Physics·F WürschmidtH P Heilmann
Feb 1, 1995·Journal of the National Cancer Institute·R ArriagadaS Benhamou
Feb 1, 1994·Clinical Endocrinology·P M StewartA White
Dec 16, 1993·The New England Journal of Medicine·R ArriagadaP Ruffié
Feb 8, 1993·Archives of Internal Medicine·T UrbanJ Sauvaget
Mar 15, 1996·International Journal of Radiation Oncology, Biology, Physics·A G Van OosterhoutA Twijnstra

❮ Previous
Next ❯

Citations

Oct 7, 2005·Cancer Chemotherapy and Pharmacology·Keiichi FujiwaraMitsune Tanimoto
Feb 18, 2011·Cancer Chemotherapy and Pharmacology·Zheng-tao ZhouXu-shen Peng
Apr 16, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Lori J WirthBruce E Johnson
Jun 5, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Caio M Rocha Lima, Alberto Chiappori
Oct 10, 2006·Clinical Lung Cancer·Rogerio C LilenbaumPaul Wissel
Jun 23, 2010·Asia-Pacific Journal of Clinical Oncology·Thep ChalermchaiVirote Sriuranpong
Jun 23, 2004·Critical Reviews in Oncology/hematology·A RossiC Gridelli
Apr 20, 2004·Hematology/oncology Clinics of North America·Michael Dusmet, Peter Goldstraw
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H Johnson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
W Schuette
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
S AgelakiA Raptis
International Journal of Environmental Research and Public Health
Richard F GillumThomas O Obisesan
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
Gregory P Kalemkerian
© 2022 Meta ULC. All rights reserved